Clin2
NCT06222723Possibly a fitRecruiting

Testing dexamethasone as an additional treatment for Lassa fever

Lassa Fever

Treatments studied

Part of Infections clinical trials.

This trial tests whether adding dexamethasone, a steroid that reduces inflammation, to standard care can help people with severe Lassa fever. It is for adults who are very sick with confirmed Lassa fever.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
42 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years or older.
  • Lassa fever must be confirmed by a lab test with high levels of the virus.
  • You must have signs of serious illness, such as confusion, low blood pressure, seizures, bleeding, or low oxygen levels.
  • You must not be pregnant or breastfeeding.
  • You must not have had steroids in the last 7 days or be allergic to ribavirin or dexamethasone.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06212336Recruiting· Phase 2/Phase 3
Lassa fever treatment with antiviral combinations

This trial tests different combinations of antiviral drugs (favipiravir, ribavirin, and a steroid called dexamethasone) in adults hospitalized with Lassa fever. The goal is to find the safest and most effective treatment.

Suacoco, Bong County
NCT05868733Recruiting· Phase 2
Lassa fever vaccine study for people in West Africa

This trial tests an investigational vaccine to prevent Lassa fever, a serious illness found in parts of West Africa. People in different age groups will get the vaccine or a placebo and be followed to see if it’s safe and helps the immune system respond.

Accra
NCT07681752Not yet recruiting
Testing a faster Ebola and Lassa virus diagnostic

This study checks a new, faster test for Ebola and Lassa viruses using stored blood samples from past infections. It compares the new test's results with the original diagnosis to see if the quick test is accurate.

NCT07543458Not yet recruiting· Phase 3
Testing treatments for serious dengue fever in hospitalized patients

This study tests new medicines for people hospitalized with moderate-to-severe dengue fever. Dengue is a mosquito-borne virus that can cause serious complications like severe bleeding, organ damage, or shock. The trial aims to find treatments that help patients recover faster and avoid life-threatening complications.

Chittagong
NCT05631405Recruiting
Dexamethasone for serious dengue with warning signs

This trial studies whether dexamethasone (a steroid medicine) can help people with dengue infection who have warning signs and are still in the fever stage. It may help reduce complications like breathing problems, severe bleeding, or organ stress, but it is only for a specific window and situation.

Bangkok
NCT07584525Recruiting· Phase 3
Dexamethasone treatment for tick-borne encephalitis

This study tests whether a steroid medication called dexamethasone can help people with tick-borne encephalitis, a serious brain infection spread by ticks. The goal is to see if this treatment reduces inflammation in the brain and improves recovery.

Ljubljana

Hear when a new Lassa Fever trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.